Long Corridor Asset Management LTD Bei Gene, Ltd. Transaction History
Long Corridor Asset Management LTD
- $80.6 Million
- Q2 2024
A detailed history of Long Corridor Asset Management LTD transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Long Corridor Asset Management LTD holds 52,623 shares of BGNE stock, worth $10.7 Million. This represents 9.32% of its overall portfolio holdings.
Number of Shares
52,623
Previous 10,046
423.82%
Holding current value
$10.7 Million
Previous $1.57 Million
377.85%
% of portfolio
9.32%
Previous 2.29%
Shares
9 transactions
Others Institutions Holding BGNE
# of Institutions
216Shares Held
42MCall Options Held
106KPut Options Held
93.1K-
Baker Bros. Advisors LP New York, NY10.6MShares$2.14 Billion20.04% of portfolio
-
Capital International Investors Los Angeles, CA7.01MShares$1.42 Billion0.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$1.05 Billion19.1% of portfolio
-
Primecap Management CO Pasadena, CA4.99MShares$1.01 Billion0.52% of portfolio
-
Baillie Gifford & CO3.68MShares$746 Million0.42% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $21B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...